Paper86392
Bleomycin pharmacokinetics in man. I. Intravenous administration.
Alberts DS and 9 others. Cancer Chemother Pharmacol, 1978. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Bleomycin pharmacokinetics in man. I. Intravenous administration. Papers, record 86392. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/86392
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bleomycin | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Injections, Intravenous | |
| Kinetics | |
| Male | |
| Middle Aged | |
| Neoplasms | |
| Radioimmunoassay | |
| Time Factors |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4122362 | A clinical review of bleomycin--a new antineoplastic agent. | Cancer | 1973 | https://conductscience.org/library/papers/4122362 | PubMed |
| 2 | 66973 | Bleomycin serum pharmacokinetics as determined by a radioimmunoassay and a microbiologic assay in a patient with compromised renal function. | Cancer | 1977 | https://conductscience.org/library/papers/66973 | PubMed |
| 3 | 5953301 | New antibiotics, bleomycin A and B. | J Antibiot (Tokyo) | 1966 | https://conductscience.org/library/papers/5953301 | PubMed |
| 4 | 74282 | Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus. | Cancer Treat Rep | 1977 | https://conductscience.org/library/papers/74282 | PubMed |
| 5 | 62609 | Intracavitary bleomycin in the management of malignant effusions. | Cancer | 1976 | https://conductscience.org/library/papers/62609 | PubMed |
| 6 | 4132697 | Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance. | Cancer | 1974 | https://conductscience.org/library/papers/4132697 | PubMed |
| 7 | 134142 | CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates. | J Pharm Sci | 1976 | https://conductscience.org/library/papers/134142 | PubMed |
| 8 | 4131335 | Letter: New components of bleomycin. | J Antibiot (Tokyo) | 1973 | https://conductscience.org/library/papers/4131335 | PubMed |
| 9 | 4427218 | Statistical estimations in pharmacokinetics. | J Pharmacokinet Biopharm | 1974 | https://conductscience.org/library/papers/4427218 | PubMed |
| 10 | 4131336 | Letter: Chemistry of bleomycin. XI. The structures of the terminal amines. | J Antibiot (Tokyo) | 1973 | https://conductscience.org/library/papers/4131336 | PubMed |
| 11 | 72602 | Specificity of antisera produced against bleomycin. | Cancer Treat Rep | 1977 | https://conductscience.org/library/papers/72602 | PubMed |
| 12 | 56999 | Radioimmunoassay of bleomycin. | Cancer Res | 1976 | https://conductscience.org/library/papers/56999 | PubMed |
| 13 | 4118759 | Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients. | Ann Intern Med | 1972 | https://conductscience.org/library/papers/4118759 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29734689 | The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNA. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29734689 | PubMed |
| 28160575 | Safety and efficacy of bleomycin/pingyangmycin-containing chemotherapy regimens for malignant germ cell tumor patients in the female genital system. | Oncotarget | 2017 | https://conductscience.org/library/papers/28160575 | PubMed |
| 25590623 | Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage. | PLoS One | 2015 | https://conductscience.org/library/papers/25590623 | PubMed |
| 23450195 | Tumor size and effectiveness of electrochemotherapy. | Radiol Oncol | 2013 | https://conductscience.org/library/papers/23450195 | PubMed |
| 16012866 | Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge. | J Cancer Res Clin Oncol | 2005 | https://conductscience.org/library/papers/16012866 | PubMed |
| 7318146 | Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7318146 | PubMed |
| 6207949 | Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6207949 | PubMed |
| 6189661 | Clinical pharmacokinetics of commonly used anticancer drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6189661 | PubMed |
| 6155927 | Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration. | Br J Cancer | 1980 | https://conductscience.org/library/papers/6155927 | PubMed |
| 6088712 | Chemosensitivity of malignant human brain tumors. Preliminary results. | J Neurooncol | 1983 | https://conductscience.org/library/papers/6088712 | PubMed |
| 4053266 | In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4053266 | PubMed |
| 4039488 | Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line. | Urol Res | 1985 | https://conductscience.org/library/papers/4039488 | PubMed |
| 3555940 | Pharmacokinetics of anticancer drugs in children. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3555940 | PubMed |
| 3054425 | Clinical management of cytotoxic drug overdose. | Med Toxicol Adverse Drug Exp | 1988 | https://conductscience.org/library/papers/3054425 | PubMed |
| 2443992 | Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats. | Thorax | 1987 | https://conductscience.org/library/papers/2443992 | PubMed |
| 2426030 | Pharmacokinetic drug interactions of commonly used anticancer drugs. | Clin Pharmacokinet | 1986 | https://conductscience.org/library/papers/2426030 | PubMed |
| 1711838 | Mechanisms of bleomycin-induced lung damage. | Arch Toxicol | 1991 | https://conductscience.org/library/papers/1711838 | PubMed |
| 1696567 | Phase I trial of tallysomycin S10b, a bleomycin analogue. | Invest New Drugs | 1990 | https://conductscience.org/library/papers/1696567 | PubMed |
| 93987 | Pharmacokinetics of bleomycin in man. III. Bleomycin 57Co Vs bleomycin. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/93987 | PubMed |
| 93985 | Bleomycin pharmacokinetics in man. II. Intracavitary administration. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/93985 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/86392
GET https://conductscience.org/api/papers/v1/86392/authors